NRIX vs TER · rev $54.5M vs P/E 76, rev $2.82B
Nurix Therapeutics Inc (NRIX) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
NRIX currently screens at market cap $1.77B. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the NRIX and TER stock pages for the full models.
Not investment advice.